Following co-administration of oral posaconazole (400 mg twice daily) with atazanavir and ritonavir (300/ 100 mg once daily) for 7 days in healthy subjects Cmax and AUC of atazanavir increased by an average of 1.5-fold and 2.5-fold (range 0.9 to 4.1-fold), respectively.